About the Simpson Lab
Cory Simpson, MD, launched his laboratory at the University of Washington in 2021 to study the epidermis and how it is compromised in dermatologic disease. Using a 3D human skin model coupled with advanced microscopy, his lab can visualize the live tissue at the level of single organelles to understand how the epidermis forms and how disease-linked mutations disrupt the tissue to cause skin fragility and blistering. Ultimately, the Simpson Lab aims to identify novel treatment strategies to drive epidermal tissue regeneration, promote wound healing, and restore the skin barrier in incurable skin fragility disorders and blistering diseases like Darier disease, Hailey-Hailey disease, ichthyosis, and epidermolysis bullosa (EB).
The Simpson Lab is located at the UW Medicine South Lake Union (SLU) Campus, an innovative biomedical research hub in Seattle that is connected to the Fred Hutchinson Cancer Research Center and the main UW campus by shuttle.
Dr. Simpson is a member of the Institute for Stem Cell and Regenerative Medicine (ISCRM) at UW, which offers access to outstanding core resources for imaging, stem cells, gene editing, genomics, and high-throughput screening of drug compounds.
Funding
The Simpson Lab is grateful for current and prior support from the following organizations.
If you would like to support the Simpson Lab’s research, click here to donate through UW Medicine.
